Bumper Offer - Urjas oil Just @ Rs. 1
Keto Soap 100gm is a prescription drug, available for use as Soap. Fungal Infections are some of its major therapeutic uses. The alternative uses of Keto Soap 100gm have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Keto Soap 100gm. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Keto Soap 100gm as well, which are listed below. These side effects of Keto Soap 100gm are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Keto Soap 100gm's effect is Moderate during pregnancy and Safe for lactating mothers. Further, the section on Keto Soap 100gm related warnings talks about Keto Soap 100gm's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Liver Disease must refrain from the use of Keto Soap 100gm since this can cause severe adverse effects. Other conditions have been mentioned below in the Keto Soap 100gm contraindications section.
Drug reaction of Keto Soap 100gm with other medicines has been reported. See below for a complete list.
You should also be aware that Keto Soap 100gm is not safe while driving, and is not addiction.
Keto Soap 100gm is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Keto Soap 100gm is used -
Moderate
Mild
Is the use of Keto Soap 100gm safe for pregnant women?
Pregnant women may experience moderate side effects from Keto. It is best to stop taking Keto immediately and inform your doctor if you notice any discomfort.
Is the use of Keto Soap 100gm safe during breastfeeding?
Keto does not show any side effects in breastfeeding women.
What is the effect of Keto Soap 100gm on the Kidneys?
Keto is completely safe for kidneys.
What is the effect of Keto Soap 100gm on the Liver?
Use of Keto may be dangerous for the liver. Do not use it without doctor's advice.
What is the effect of Keto Soap 100gm on the Heart?
Side effects of Keto rarely affect the heart.
Keto Soap 100gm should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Keto Soap 100gm unless your doctor advises you to do so -
Is this Keto Soap 100gm habit forming or addictive?
Keto Soap 100gm is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Keto Soap 100gm can make you feel drowsy.
Is it safe?
Yes, Keto Soap 100gm is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Keto Soap 100gm is unable to treat or cure mental disorders.
Interaction between Food and Keto Soap 100gm
Taking Keto Soap 100gm with food does not harm your health.
Interaction between Alcohol and Keto Soap 100gm
Taking Keto Soap 100gm with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
